Status:
RECRUITING
Immunonutrition in ERAS Protocols in Gynecologic Oncology
Lead Sponsor:
National and Kapodistrian University of Athens
Conditions:
Nutritional Deficiency
Gynecologic Cancer
Eligibility:
FEMALE
20-80 years
Phase:
NA
Brief Summary
A patient with oncological pathology of any type because of impaired digestion and nutrient absorption, decreased intake, and increased nutrition requirements has an increased risk of malnutrition and...
Detailed Description
Malnutrition has a major effect not only on the postoperative course of cancer surgery but can also complicate or even limit administration or compromise the effectiveness of other treatments such as ...
Eligibility Criteria
Inclusion
- women with any gynaecologic malignancy enrolled in surgical list of our institute
- must be able to consume oral supplements.
Exclusion
- women that are not able to follow ERAS protocol due to medical reasons
- patients with severe disease that cannot compromise with protocol
Key Trial Info
Start Date :
October 18 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 30 2025
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06103526
Start Date
October 18 2023
End Date
August 30 2025
Last Update
March 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
First department of Obstetrics and Gynecology
Athens, Greece, 11523